[{"bbox": [90, 101, 367, 132], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [90, 204, 547, 233], "category": "Section-header", "text": "## Statement of Profit and Loss after Tax"}, {"bbox": [90, 236, 2240, 300], "category": "Text", "text": "The reconciliation of Profit/(loss) after tax as per audited results and the Profit/(loss) after tax as per Restated accounts is presented below in Table-1. This summarizes the results of restatements made in the audited accounts for the respective years and its impact on the respective year profit & losses of the company."}, {"bbox": [1872, 300, 2132, 329], "category": "Text", "text": "(Amount in Lakhs Rs.)"}, {"bbox": [90, 327, 2240, 1392], "category": "Table", "text": "<table><thead><tr><th>Particulars</th><th>3/31/2025</th><th>3/31/2024</th><th>3/31/2023</th></tr></thead><tbody><tr><td>Net Profit/(loss) after Tax as per audited accounts but before adjustments for restated accounts:(a)</td><td>1,921.11</td><td>3,863.20</td><td>3,866.25</td></tr><tr><td>Less: Provision for Gratuity booked as per AS -15(Revised)</td><td>208.30</td><td>(23.66)</td><td>(12.90)</td></tr><tr><td>Short/(Excess) Provision for Deferred Tax Assets</td><td>(1.88)</td><td>(12.95)</td><td>12.40</td></tr><tr><td>(Short)/Excess Provision for Income Tax</td><td>(122.14)</td><td>78.85</td><td>46.64</td></tr><tr><td>(Short)/Excess Provision for Depreciation</td><td>(28.75)</td><td>31.79</td><td>(32.65)</td></tr><tr><td>Short/(Excess) Capitalization of Borrowing cost</td><td>-</td><td>89.20</td><td>72.13</td></tr><tr><td>(Short)/Excess Interest on TDS, Interest and Demand on GST, Penalty on Custom Duty routed through P&L instead of Reserve & Surplus account of current year</td><td>-</td><td>(43.48)</td><td>0.43</td></tr><tr><td>(Short)/Excess Penalty on Custom Duty routed through P&L instead of Reserve & Surplus account of current year</td><td>-</td><td>-</td><td>(0.07)</td></tr><tr><td>(Short)/Excess Adjustment of Foreign Exchange Gain/(loss) working</td><td>25.35</td><td>0.37</td><td>(125.42)</td></tr><tr><td>(Short)/Excess Adjustment of Accrued Interest on Term loans & Other loans</td><td>24.94</td><td>(12.37)</td><td>(6.24)</td></tr><tr><td>(Short)/Excess Adjustment of Provision of Doubtful Debts</td><td>239.92</td><td>(81.43)</td><td>(42.64)</td></tr><tr><td>(Short)/Excess Adjustment of Deferred Revenue Expenditure written off with opening reserve</td><td>1.79</td><td>-</td><td>-</td></tr><tr><td>Short/(Excess) Adjustment of Income booked on FDR as per bank Balances</td><td>(2.58)</td><td>10.74</td><td>(3.67)</td></tr><tr><td>Short/(Excess) Adjustment of consumable expenses related to R&D of last year booked in FY 2024-25</td><td>83.26</td><td>(83.26)</td><td>-</td></tr><tr><td>Short/(Excess) Adjustment of Service charges Income (AMC)</td><td>56.70</td><td>(15.29)</td><td>(35.37)</td></tr><tr><td>Short/(Excess) Capitalization of R& D Expenses</td><td>(379.20)</td><td>379.20</td><td>-</td></tr><tr><td>(Short)/Excess Adjustment of Provision of Non-Moving stock as estimated by management</td><td>60.94</td><td>(39.44)</td><td>(21.50)</td></tr><tr><td>(Short)/Excess Adjustment of Loss on Discard of FA which already write off in Restated in earlier period</td><td>0.79</td><td>-</td><td>-</td></tr><tr><td>(Short)/Excess Provision for Income Tax of earlier year- short provision</td><td>61.70</td><td>(61.70)</td><td>(59.31)</td></tr><tr><td>Short/(Excess) Adjustment of Prior period Expenses/Income</td><td>653.88</td><td>(598.96)</td><td>(62.82)</td></tr><tr><td>Income Tax of PSHPL Not Considered in Consolidated</td><td>-</td><td>(10.34)</td><td>(366.70)</td></tr><tr><td>(short)/Excess Adjustment of Loss from Q-line nutraceuticals in Consolidated Financials</td><td>8.95</td><td>(17.07)</td><td>-</td></tr><tr><td>(short)/Excess Adjustment of Loss from Q-line IRIS in Consolidated Financials</td><td>-</td><td>(0.17)</td><td>-</td></tr><tr><td>Reserve & Surplus of POCT Science House Pvt Ltd not considered in Consolidated financials</td><td>-</td><td>(8.76)</td><td>(18.83)</td></tr><tr><td>Net Adjustment in Profit and Loss Account (b)</td><td>891.98</td><td>(418.73)</td><td>(656.54)</td></tr><tr><td>Net Profit/(Loss) After Tax as per Restated Accounts:(a+b)</td><td>2,813.09</td><td>3,444.47</td><td>3,209.71</td></tr></tbody></table>"}, {"bbox": [1146, 1485, 1187, 1513], "category": "Page-footer", "text": "197"}]